These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22550317)

  • 1. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study.
    Gunnarsson R; Aaløkken TM; Molberg Ø; Lund MB; Mynarek GK; Lexberg AS; Time K; Dhainaut AS; Bertelsen LT; Palm O; Irgens K; Becker-Merok A; Nordeide JL; Johnsen V; Pedersen S; Prøven A; Garabet LS; Gran JT
    Ann Rheum Dis; 2012 Dec; 71(12):1966-72. PubMed ID: 22550317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature.
    Gunnarsson R; Andreassen AK; Molberg Ø; Lexberg ÅS; Time K; Dhainaut AS; Bertelsen LT; Palm Ø; Irgens K; Becker-Merok A; Nordeide JL; Johnsen V; Pedersen S; Prøven A; Garabet LS; Garen T; Aaløkken TM; Gilboe IM; Gran JT
    Rheumatology (Oxford); 2013 Jul; 52(7):1208-13. PubMed ID: 23407386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary involvement in long-term mixed connective tissue disease: functional trends and image findings after 10 years.
    Kawano-Dourado L; Baldi BG; Kay FU; Dias OM; Gripp TE; Gomes PS; Fuller R; Caleiro MT; Kairalla RA; Carvalho CR
    Clin Exp Rheumatol; 2015; 33(2):234-40. PubMed ID: 25896472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chest abnormalities in juvenile-onset mixed connective tissue disease: assessment with high-resolution computed tomography and pulmonary function tests.
    Aaløkken TM; Lilleby V; Søyseth V; Mynarek G; Pripp AH; Johansen B; Førre O; Kolbenstvedt A
    Acta Radiol; 2009 May; 50(4):430-6. PubMed ID: 19277918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease.
    Gunnarsson R; El-Hage F; Aaløkken TM; Reiseter S; Lund MB; Garen T; ; Molberg Ø
    Rheumatology (Oxford); 2016 Jan; 55(1):103-8. PubMed ID: 26320136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Manifestations and Progression of Lung Disease in Juvenile-onset Mixed Connective Tissue Disease.
    Hetlevik SO; Flatø B; Aaløkken TM; Lund MB; Reiseter S; Mynarek GK; Nordal E; Rygg M; Lilleby V
    J Rheumatol; 2019 Jan; 46(1):93-100. PubMed ID: 30068767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD).
    Bodolay E; Szekanecz Z; Dévényi K; Galuska L; Csípo I; Vègh J; Garai I; Szegedi G
    Rheumatology (Oxford); 2005 May; 44(5):656-61. PubMed ID: 15716315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography.
    Afeltra A; Zennaro D; Garzia P; Gigante A; Vadacca M; Ruggiero A; Dardes N; Navajas MF; Zobel BB; Amoroso A
    Scand J Rheumatol; 2006; 35(5):388-94. PubMed ID: 17062440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test.
    Andersen CU; Mellemkjær S; Hilberg O; Nielsen-Kudsk JE; Simonsen U; Bendstrup E
    Respir Med; 2012 Jun; 106(6):875-82. PubMed ID: 22425136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study.
    Reiseter S; Gunnarsson R; Mogens Aaløkken T; Lund MB; Mynarek G; Corander J; Haydon J; Molberg Ø
    Rheumatology (Oxford); 2018 Feb; 57(2):255-262. PubMed ID: 28379478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
    Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
    Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of interstitial lung disease in mixed connective tissue disease].
    Colin G; Nunes H; Hatron PY; Cadranel J; Tillie I; Wallaert B
    Rev Mal Respir; 2010 Mar; 27(3):238-46. PubMed ID: 20359616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.
    Kocheril SV; Appleton BE; Somers EC; Kazerooni EA; Flaherty KR; Martinez FJ; Gross BH; Crofford LJ
    Arthritis Rheum; 2005 Aug; 53(4):549-57. PubMed ID: 16082627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters.
    Fischer A; Swigris JJ; Bolster MB; Chung L; Csuka ME; Domsic R; Frech T; Hinchcliff M; Hsu V; Hummers LK; Gomberg-Maitland M; Mathai SC; Simms R; Steen VD
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-109-14. PubMed ID: 25372796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary involvement in patients with childhood-onset systemic lupus erythematosus.
    Lilleby V; Aaløkken TM; Johansen B; Førre Ø
    Clin Exp Rheumatol; 2006; 24(2):203-8. PubMed ID: 16762160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct phenotypes in mixed connective tissue disease: subgroups and survival.
    Szodoray P; Hajas A; Kardos L; Dezso B; Soos G; Zold E; Vegh J; Csipo I; Nakken B; Zeher M; Szegedi G; Bodolay E
    Lupus; 2012 Nov; 21(13):1412-22. PubMed ID: 22864236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease.
    Hesselstrand R; Andréasson K; Wuttge DM; Bozovic G; Scheja A; Saxne T
    Rheumatology (Oxford); 2012 May; 51(5):915-20. PubMed ID: 22253028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of endothelial dysfunction and coagulation disorders in the development of pulmonary fibrosis in patients with interstitial lung diseases].
    Ppova EN; Arkhipova DV; Kozlovskaia LV; Privalova EV; Bitsadze VO; Kornev BM
    Klin Med (Mosk); 2004; 82(6):38-42. PubMed ID: 15344689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.